CD40LG and Abnormal renal physiology: analyzed 38 cases of IgM‐MGRS, reporting that patients who responded to immunochemotherapy had a shorter interval between the onset of renal dysfunction and kidney biopsy (2.9 vs. 6.9 months, p = 0.035) [13].